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Cognitive remediation refers to nonpharmacological methods of improving cognitive function in people with severe mental
disorders. Cognitive remediation therapy (CRT) can be delivered via computerised programs, of varying length and complexity,
or can be undertaken one-on-one by a trained clinician. There has been a considerable interest in cognitive remediation, driven
by recognition that cognitive deficits are a major determinant of outcome in people with severe, chronic mental illnesses. CRT has
been shown to be effective, especially if combined with vocational rehabilitation.
1. Cognitive Impairment in
Severe Mental Illness
The term “severe mental illness” (SMI) is generally taken to
encompass chronic psychotic disorders. Whilst many people
in this category suffer from schizophrenia, disorders such
as schizoaffective disorder, delusional disorder and bipolar
disorder are also commonly associated with persistent symp-
toms, cognitive impairment and long-termdisability [1]. Data
collected from 1875 people with SMI demonstrated that their
current cognitive ability was markedly impaired, compared
to the general population. On average, people with psychosis
scored 1.6 standard deviations below the general population
on a test of information processing speed [1].
There are some differences between diagnostic groups.
Children who later develop schizophrenia are more likely to
be slow to learn to speak [2] and to have impaired language
and arithmetic ability during childhood [3], reflecting neu-
rodevelopmental processes underlying adult schizophrenia
[4]. In contrast, people with bipolar disorder tend to have
average or superior educational achievement as children, sug-
gesting a different illness trajectory [5]. Nevertheless, despite
premorbid differences, cognitive impairment is evident in
both affective psychoses (bipolar disorder and psychotic
depression) and nonaffective psychoses (schizophrenia) [6]
even in the early stages of the disorder. Cognitive impairment
is generally most profound and pervasive in schizophrenia
[7].
Vocational outcomes are poor in people with SMI, with
many experiencing long-term unemployment and welfare
dependence, despite evidence that they could gain consid-
erable benefit from engagement in paid employment [8].
Numerous studies have demonstrated an association between
the severity of cognitive impairment and functional, social,
and occupational outcomes in schizophrenia [9, 10]. Simi-
larly, in bipolar disorder, cognitive deficits have been shown
to be associated with reduced psychosocial function [11, 12].
Cognitive impairment is an important determinant of poor
engagement with vocational rehabilitation services [13] and
failure to maintain job tenure [14]. Research into measures to
improve cognition is therefore driven by the hope that such
improvements might lead to better long-term economic as
well as functional outcomes, along with greater opportunities
for social inclusion.
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A number of medications have been trialled, specifically
targeting cognitive function [15]. Treatment with clozapine is
associated with improvements in working memory although
normal levels of performance are not achieved [16]. Whilst
other atypical antipsychotic drugs have been shown to be
associated with improved cognition, it appears that much of
this improvement is an artefact of study design with failure to
properly address practice effects [17].
Very high levels of tobacco use are found amongst
people with schizophrenia [18, 19], and interestingly nicotine
improves their ability to filter out irrelevant information
and to manage complex environments [20]. Drugs acting on
nicotinic receptors may therefore have a role in enhancing
cognition in schizophrenia. A number of other targets for
drug development have been identified, but so far none of
the drugs available have shown substantial benefit in clinical
trials [15]. This lack of progress in psychopharmacology has
highlighted the need for effective nonpharmacological meth-
ods of cognitive remediation.
2. Cognitive Remediation: Study Populations
Virtually all of the research regarding cognitive remediation
in SMI has been undertaken in people with schizophrenia,
perhaps because, as described above, schizophrenia has been
shown to be associatedwith themost severe cognitive deficits.
There has been one study comparing cognitive remediation in
schizophrenia and schizoaffective disorder [21] which found
that cognitive enhancement therapy, a two-year intervention
including both computer training and social cognitive group
sessions, was equally effective in both groups. Harvey et al.
(2010) suggest that people with bipolar disorder might also
benefit from the treatments used to address cognitive deficits
in schizophrenia [22]. Deckersbach et al. (2010) have reported
that a 14-session cognitive remediation program designed
to treat both residual depressive symptoms and cognitive
impairment in people with bipolar disorder, and delivered
to each participant individually, was effective in reducing
depression and improving occupational and psychosocial
functioning.This was a small study (𝑁 = 18) with no control
group, but it does provide an indication that further research
into cognitive remediation in bipolar disorder is warranted
[23].
3. Methods of Cognitive Remediation
An expert consensus group has defined cognitive remedia-
tion Therapy (CRT) as “a behavioural-training based inter-
vention that aims to improve cognitive processes (attention,
memory, executive function, social cognition, or metacog-
nition) with the goal of durability and generalization” [24].
A variety of different methods of cognitive remediation
have been described in the research literature. The starting
point for this research was to establish whether it is pos-
sible to achieve any improvement in cognitive function in
schizophrenia using non-pharmacological methods. Some of
the earliest studies demonstrated that people with schizo-
phrenia could be taught to improve their performance on the
Wisconsin Card Sorting Test [25, 26]. Simple strategies such
as vocalisation (speaking aloud whilst performing the task)
have been shown to improve performance on complex tasks
[27]. In other early studies, computer programs developed
to retrain attentional deficits due to closed-head injury were
used with people with schizophrenia. Results were mixed,
with some studies reporting improvement [28, 29] while
others found no change [24, 30].
Next, programs were developed to target the cognitive
deficits characteristic of schizophrenia.These programs differ
considerably in their theoretical underpinnings, methods,
duration, and target outcomes. CRT programs generally take
one of two approaches, either rehearsal learning, also termed
drill and practice, or strategy coaching, where participants are
helped to develop effective strategies to undertake cognitive
tasks. Combinations of these two approaches can be utilised
[31].
Whilst earlier studies often used clinician-administered
CRT, recent studies most commonly utilise computerised
CRT. Computerised methods have the advantages of being
standardised and more efficient. Less staff time is needed as
one staffmember can supervise several participants, and staff
do not require specialised skills. The larger and more suc-
cessful studies have used programs such as Cogpack [32] and
CogRehab [31]. Cogpack and Cogrehab consist of a series of
computer-based programswhich address a range of cognitive
functions. Cognitive domains including memory, attention,
visual information processing, language, and motor function
are targeted using interactive training programs. Genevsky et
al. (2010) randomly assigned participants to either 50 hours
of playing computer games, or to 50 hours of computerised
training of auditory perception and aural speech reception for
10 weeks. These exercises were used as it is thought that early
auditory processing deficits are associated with impaired
verbal memory, reading ability and emotional recognition.
Subjects who undertook this training showed improvements
in working memory, verbal learning and memory, and global
cognition compared to the comparison group [33]. These
programs allow therapy to be extended through independent
exercise on a home computer. Computer-delivered programs
are generally acceptable to participants, especially younger
people for whom these programs resemble recreational com-
puter games. Some studies use a combination of the two
methods; for example, Royer et al. (2012) describe a combina-
tion of psychologist-assisted pencil and paper exercises and a
computerised training program [34].
4. Outcome Measures
There is a considerable variation in outcome measures,
and this makes comparison between studies difficult. The
National Institute of Mental Health (NIMH) MATRICS
(Measurement and Treatment Research to Improve Cogni-
tion in Schizophrenia) initiative attempted to address the lack
of standardization of instruments used to measure cognition
in schizophrenia. A consensus neuropsychological battery
of 10 tests [35, 36] was developed to evaluate performance
across seven domains previously shown to be impaired in
schizophrenia. These domains are speed of processing,
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attention/vigilance, working memory, verbal learning, visual
learning; reasoning and problem solving; and social cogni-
tion. Normative data for the MATRICS test battery has been
obtained on 300 adults [35]. However, despite the availability
of the MATRICS battery, a wide range of outcome measures
continue to be used in research evaluating CRT [36].
5. Efficacy of CRT
Wykes et al. (2007) described a study using a clinician-
delivered CRT program in young people with schizophrenia.
The program required 40 hours of individual work with
each patient [37]. Tasks were designed to improve informa-
tion processing strategies and included memory, complex
planning, and problem solving. Three cognitive outcome
measures were selected, and comparisons between the CRT
group and the control group found statistically significant
improvement in only one of these measures, with no signifi-
cant effect of CRT on symptom severity or social functioning.
There was some controversy about whether such modest
gains are worth the investment of time and expertise [38].
However, in a meta-analysis of 40 studies of cognitive
remediation in schizophrenia, Wykes et al. (2011) found
that CRT resulted in significant improvements in global
cognition with a mean effect size of 0.45. Nearly all cognitive
domains, including attention and vigilance, speed of pro-
cessing, working memory, reasoning, problem solving, and
social cognition demonstrated significant effect sizes ranging
from 0.25 to 0.65. Importantly, the effects on global cognition
were sustained 3–12 months after CRT was completed (effect
size = 0.43). The average length of treatment was 32.3 hours
provided across 16.7 weeks; however the sample size in most
studies was small, ranging from 10 to 145 people. Wykes et al.
(2011) concluded that CRT can provide benefits to patients
with cognitive difficulties independent of therapy charac-
teristics such as individual versus group therapy, patient
characteristics or sample size [39].
Wykes et al. (2011) also proposed that nearly all cog-
nitive domains respond to remediation in the treatment
of schizophrenia. As cognitive remediation is not domain
specific they propose that the outcome measure of any
cognitive remediation therapy should be the effect it has on
community functioning [39].
6. Real-World Applications of CRT
Improving performance on cognitive tests is not in itself of
benefit; the goals of CRT are to improve real-world outcomes
such as work, socialisation, and independent living skills.
One of the shortcomings in CRT research has been that
this therapy has often been provided without concurrent
rehabilitation programs, and the more successful studies do
combine CRT and psychosocial and/or vocational rehabili-
tation. For example, McGurk and Meltzer (2000) found that
a combination of computer-aided CRT and vocational reha-
bilitation was more successful in returning people to work
than vocational rehabilitation alone [32]. A meta-analysis
by McGurk et al. (2007) reported that studies that included
adjunctive psychiatric rehabilitation had significantly better
outcomes, compared with cognitive remediation alone [40].
This makes sense as participants have the opportunity to
apply their improved cognitive skills directly to the challenges
of the workplace, resulting in iterative learning opportunities.
This is supported by a meta-analysis that concluded that
CRT was more effective when it was provided with other
adjunctive psychiatric rehabilitation [39]. In the short term,
the CRT programs which focussed solely on cognitive skills
had a small to medium effect size but demonstrated no sig-
nificant difference at followup assessment [39]. These results
indicate that in order to maximise the benefits of CRT, par-
ticipants should be working or be involved in employment-
focused rehabilitation.This important finding, reportedmore
than a decade ago, has nevertheless not beenwidely translated
into services for people with SMI.
CRT has also been shown to improve symptoms in
schizophrenia. Participants in a study by Lecardeur et al.
(2009) received 2 novel CRTs, one targetingmental state attri-
bution, and the other, mental flexibility, and compared both
groups with a control group given treatment as usual. Symp-
tomsdecreased after therapy, but not in the control group.The
mental flexibility group showed the most improvement [41].
Additionally, this study reported that participants described
a subjective reduction of their cognitive deficits.
On the whole, CRT has been shown to have moderate
improvements on global cognition and to a lesser extent
functioning. However, greater improvement in functional
outcomes can be achieved by combining psychosocial reha-
bilitation and CRT [40].
7. Remediation of Social Cognitive Deficits
Social cognition is a domain of cognitive function that
includes the ability to understand and manage social interac-
tions. Social cognition refers to aspects of cognition that are
critical for social functioning and interpersonal relationships,
such as accurate perception of the emotions of others, the
ability to recognize important social cues, theory of mind
(TOM), and the management of emotions in social situations
[42]. Various components of social cognition have been
found to be impaired in people with schizophrenia [43, 44].
Lindenmayer et al. (2012) concluded that CRT combinedwith
emotion perception remediation produced greater improve-
ments in emotion recognition, emotion discrimination,
social functioning, and neurocognition compared with CRT
alone in chronic schizophrenia [45]. Furthermore, as has
been shown previously in cognitive remediation research,
training in one area of cognition can generalise to other social
cognition domains whichwere not the primary focus of treat-
ment [46]. Penade´s et al. (2010) reported that improvement in
executive functioning predicted improved daily functioning
and social cognition among people with schizophrenia who
had negative symptoms and neuropsychological impairment
[47]. This provides further support for the generalizability
of CRT training to a variety of cognitive domains. A meta-
analysis of computerised CRT found a significant medium
effect size of 0.64 (CI 0.29–0.99) for Social Cognition [48].
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8. Remediation of Cognitive Biases
Cognitive illusions or biases are perceptions or judgements
that deviate from reality in a systematic way and reflect
inherent thinking errors made in processing information.
Metacognitive training (MCT) has been developed as a
treatment for people with schizophrenia to address cognitive
biases thought to contribute to delusions [49]. MCT is a
combination of psychoeducation, cognitive remediation, and
cognitive-behavioural therapy (CBT). CBT is a focussed
approach to therapy that helps individuals to identify unhelp-
ful thoughts or behaviours and to learn healthy thought
patterns and habits. By contrast, CRT is conceptualised as
a behavioural-based training program for various areas of
neurocognition and executive functioning which has gen-
eralizable effects on functioning. By combining these two
therapeutic approaches MCT educates people about their
cognitive biases and teaches them strategies to deal with
biases which may impact on functioning [49].
MCT has been shown to be effective in retraining
the “jumping to conclusions” bias and in theory of mind
[50]. Balzan et al. (in press) enrolled 24 participants with
schizophrenia and a history of delusions to a metacognitive
training program. In one-hour individual sessions, partici-
pants were encouraged to think about the cognitive under-
pinnings of delusional ideation and to consider that their
delusions may be maintained by a hypersalience of evidence-
hypothesis matches [51]. Hypersalience of evidence-hypo-
thesis matches is one type of “jumping to conclusions” bias,
where people make strong connections between existing
beliefs and weak evidence [51, 52]. After two weeks of MCT,
the severity of the delusions, and the extent of delusional
preoccupation and conviction, had decreased compared to a
treatment as usual comparison group [51].
9. The Future of CRT
As yet, CRT has not been commonly adopted in clinical
practice. Wykes, writing in Nature (2010), proposes that the
future of CRT lies in a more personalised approach. She sug-
gests that research participants should be stratified, perhaps
according to age or learning style, to identify the methods
that are most effective according to these individual factors
[38]. The goal would be to tailor an optimal remediation
program for each individual. Ultimately, biological research
methods utilising biomarkers or brain imaging might have
a role in investigating the effects of CRT on brain function,
and eventually in matching the treatment approach to the
individual patient.
Clinically the future of CRTmost likely lies in developing
effective programs that combine CRT and psychosocial and
vocational rehabilitation. Although the outcome measures
differ, comparison between the results of clinician-delivered
programs [37] and computerised CRT programs suggest that
the computerised programs are generally equally effective
[48]. Computerised programs are more likely to be adopted
in clinical practice, with clinician-delivered programs used
primarily for research. CRT programs would need to be stan-
dardised with built in measures of efficacy, so that they easily
set up in community mental health services, require minimal
staff supervision, and demonstrate sufficient improvement to
justify the ongoing commitment of resources. Future research
in this area should continue to look at the optimal modality
for CRT and the effects on particular domains of cognition as
well as evaluating the impact on general functional outcome.
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